Novartis AG - Accounts Payable

Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Accounts-Payable" stands at 4.27 Billion United States Dollars as of 06/30/2026, the lowest value since 06/30/2025.

As of the end of Novartis AG's second quarter, the item "Accounts Payable" stands at 4.27 Billion USD. This represents a decrease of -1.51 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -5.25 percent compared to the value the year prior.
The 1 year change in percent is -5.25.
The 3 year change in percent is -20.20.
The 5 year change in percent is -11.26.
The 10 year change in percent is -13.22.

The Serie's long term average value is 4.87 Billion United States Dollars. It's latest available value, on 06/30/2026, is 12.32 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2023, to it's latest available value, on 06/30/2026, is +10.32%.
The Serie's change in percent from it's maximum value, on 12/31/2013, to it's latest available value, on 06/30/2026, is -30.55%.